GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (FRA:BSX) » Definitions » Cyclically Adjusted PB Ratio

Boston Scientific (FRA:BSX) Cyclically Adjusted PB Ratio : 8.30 (As of Apr. 30, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Boston Scientific Cyclically Adjusted PB Ratio?

As of today (2024-04-30), Boston Scientific's current share price is €68.00. Boston Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €8.19. Boston Scientific's Cyclically Adjusted PB Ratio for today is 8.30.

The historical rank and industry rank for Boston Scientific's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:BSX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.06   Med: 4.98   Max: 7.94
Current: 7.87

During the past years, Boston Scientific's highest Cyclically Adjusted PB Ratio was 7.94. The lowest was 1.06. And the median was 4.98.

FRA:BSX's Cyclically Adjusted PB Ratio is ranked worse than
87.28% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs FRA:BSX: 7.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Boston Scientific's adjusted book value per share data for the three months ended in Dec. 2023 was €12.063. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €8.19 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Boston Scientific Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Boston Scientific's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Cyclically Adjusted PB Ratio Chart

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.15 5.39 5.77 5.58 6.28

Boston Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.82 6.12 5.82 6.28 -

Competitive Comparison of Boston Scientific's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Boston Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Cyclically Adjusted PB Ratio falls into.



Boston Scientific Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Boston Scientific's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=68.00/8.19
=8.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Boston Scientific's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=12.063/129.4194*129.4194
=12.063

Current CPI (Dec. 2023) = 129.4194.

Boston Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201403 3.572 99.695 4.637
201406 3.638 100.560 4.682
201409 3.922 100.428 5.054
201412 3.945 99.070 5.154
201503 4.483 99.621 5.824
201506 4.368 100.684 5.615
201509 4.247 100.392 5.475
201512 4.308 99.792 5.587
201603 4.281 100.470 5.515
201606 4.074 101.688 5.185
201609 4.242 101.861 5.390
201612 4.686 101.863 5.954
201703 4.817 102.862 6.061
201706 4.699 103.349 5.884
201709 4.638 104.136 5.764
201712 4.313 104.011 5.367
201803 4.132 105.290 5.079
201806 4.799 106.317 5.842
201809 5.134 106.507 6.238
201812 5.539 105.998 6.763
201903 5.875 107.251 7.089
201906 5.994 108.070 7.178
201909 6.318 108.329 7.548
201912 8.953 108.420 10.687
202003 8.928 108.902 10.610
202006 9.703 108.767 11.545
202009 9.228 109.815 10.875
202012 8.894 109.897 10.474
202103 9.295 111.754 10.764
202106 9.307 114.631 10.508
202109 9.821 115.734 10.982
202112 10.320 117.630 11.354
202203 10.630 121.301 11.341
202206 11.414 125.017 11.816
202209 12.441 125.227 12.858
202212 11.574 125.222 11.962
202303 11.598 127.348 11.787
202306 11.501 128.729 11.563
202309 12.080 129.860 12.039
202312 12.063 129.419 12.063

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Boston Scientific  (FRA:BSX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Boston Scientific Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific (FRA:BSX) Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific (FRA:BSX) Headlines